Long‐Term Outcomes of Living Donor Liver Transplantation for Methylmalonic Acidemia
Pediatric Transplantation · 2024
DOI: 10.1111/petr.14834 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatric Transplantation, 2024. Verfasst von Robert C Minnee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of HPB and Transplant Surgery, Department of Surgery, Erasmus Medical Center, Erasmus MC Transplant Institute, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Liver Transplantation, Living Donors, Amino Acid Metabolism, Inborn Errors, Graft Survival. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Background
Despite early diagnosis and medical interventions, patients with methylmalonic acidemia (MMA) suffer from multi‐organ damage and recurrent metabolic decompensations.
Methods
We conducted the largest retrospective multi‐center cohort study so far, involving five transplant centers (NCCHD, KUH, KUHP, ATAK, and EMC), and identified all MMA patients ( n = 38) undergoing LDLT in the past two decades. Our primary outcome was patient survival, and secondary outcomes included death‐censored graft survival and posttransplant complications.
Results
The overall 10‐year patient survival and death‐censored graft survival rates were 92% and 97%, respectively. Patients who underwent LDLT within 2 years of MMA onset showed significantly higher 10‐year patient survival compared to those with an interval more than 2 years (100% vs. 81%, p = 0.038), although the death‐censored graft survival were not statistically different (100% vs. 93%, p = 0.22). Over the long‐term follow‐up, 14 patients (37%) experienced intellectual disability, while two patients developed neurological complications, three patients experienced renal dysfunction, and one patient had biliary anastomotic stricture. The MMA level significantly decreased from 2218.5 mmol/L preoperative to 307.5 mmol/L postoperative ( p = 0.038).
Conclusions
LDLT achieves favorable long‐term patient and graft survival outcomes for MMA patients. While not resulting in complete cure, our findings support the consideration of early LDLT within 2 years of disease onset. This approach holds the potential to mitigate recurrent metabolic decompensations, and preserve the long‐term renal function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of HPB and Transplant Surgery, Department of Surgery, Erasmus Medical Center, Erasmus MC Transplant Institute, Rotterdam, The Netherlands.
- Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.
- Department of Pediatric Surgery and Transplantation, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.
- Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Department of Organ Transplantation, Atakent Hospital, Acıbadem Mehmet Ali Aydınlar University, İstanbul, Turkey.
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.
ORCID-Profile: Robert C Minnee, Seisuke Sakamoto, Akinari Fukuda, Hajime Uchida, Kazuya Hirukawa, Yitian Fang, Mureo Kasahara
Zitieren
APA
Minnee, R. C., Sakamoto, S., Fukuda, A., Uchida, H., Hirukawa, K., Honda, M., Okumura, S., Ito, T., Yilmaz, T. U., Fang, Y., Ikegami, T., Lee, K. W., Kasahara, M., & Vanguard Multi‐Center Study of International Living Donor Liver Transplantation Group (2024). Long‐Term Outcomes of Living Donor Liver Transplantation for Methylmalonic Acidemia. Pediatric Transplantation. https://doi.org/10.1111/petr.14834
Vancouver
Minnee RC, Sakamoto S, Fukuda A, Uchida H, Hirukawa K, Honda M, et al. Long‐Term Outcomes of Living Donor Liver Transplantation for Methylmalonic Acidemia. Pediatric Transplantation. 2024. doi:10.1111/petr.14834
BibTeX
@article{Minnee2024,
author = {Minnee, Robert C and Sakamoto, Seisuke and Fukuda, Akinari and Uchida, Hajime and Hirukawa, Kazuya and Honda, Masaki and Okumura, Shinya and Ito, Takashi and Yilmaz, Tonguç U and Fang, Yitian and Ikegami, Toru and Lee, Kwang W and Kasahara, Mureo and Vanguard Multi‐Center Study of International Living Donor Liver Transplantation Group, Vanguard Multi‐Center Study of International Living Donor Liver Transplantation Group},
title = {Long‐Term Outcomes of Living Donor Liver Transplantation for Methylmalonic Acidemia},
journal = {Pediatric Transplantation},
year = {2024},
doi = {10.1111/petr.14834}
}
EUVIMED